FDA Drug Recalls

Recalls / Class II

Class IID-0215-2018

Product

Shiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in a) 2mL, b) 15 mL and c) 50 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022. NDC 58411-256-60

Affected lot / code info
SKU#: a) 8C52541, b) 8B41841, c) 1155840, 1155841, 1155842, 1155851, 0710341, 0710342

Why it was recalled

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Recalling firm

Firm
SHISEIDO AMERICA INC.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
366 Princeton Hightstown Rd, N/A, East Windsor, New Jersey 08520-1411

Distribution

Quantity
N/A
Distribution pattern
Product was distributed nationwide.

Timeline

Recall initiated
2017-12-14
FDA classified
2018-01-12
Posted by FDA
2018-01-24
Terminated
2021-06-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0215-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls